832023

Baxter Healthcare Corporation — FEI 2618677

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
April 19, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Jayuya, PR (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures
890721 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration